Observational studyBMJ open diabetes research & care2020

Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs).

Cyrus Desouza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.